Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rei Matsuki"'
Autor:
Nobuyuki Yoshiyasu, Rei Matsuki, Masaaki Sato, Hirokazu Urushiyama, Etsuko Toda, Yasuhiro Terasaki, Masaki Suzuki, Aya Shinozaki-Ushiku, Yuya Terashima, Jun Nakajima
Publikováno v:
Transplant International, Vol 37 (2024)
Macrophages contribute to post-transplant lung rejection. Disulfiram (DSF), an anti-alcoholic drug, has an anti-inflammatory effect and regulates macrophage chemotactic activity. Here, we investigated DSF efficacy in suppressing acute rejection post-
Externí odkaz:
https://doaj.org/article/e599124be47545639922fef2bb35d661
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e15127- (2023)
A 70-year-old man began to cough. Chest X-ray showed a tumor in the center, pleural effusion on the left side, and diffuse granular shadows on the right side. Chest computed tomography (CT) showed bronchial wall thickening and numerous granular shado
Externí odkaz:
https://doaj.org/article/2e21d0435e454042ba2d05fc34db10ff
Publikováno v:
Respirology Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract A 37‐year‐old man was admitted to our hospital with chest pain and fever. Computed tomography showed pleural effusion and irregularly marginated, elevated lesions inside diffuse pleural thickening. Detailed medical examination showed swe
Externí odkaz:
https://doaj.org/article/c8e34040040e4b0596d22f6f19bf8a4b
Autor:
Satoru Ishii, Motoyasu Iikura, Yuriko Sugiura, Rei Matsuki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Respiratory Medicine Case Reports, Vol 38, Iss , Pp 101685- (2022)
Bronchial thermoplasty (BT) is a type of bronchoscopic treatment specifically used for patients with severe asthma. Most severe asthmatics receive systemic steroids and are at risk of being immunocompromised. This raises the clinical question of whet
Externí odkaz:
https://doaj.org/article/ec5466cf39c44d908918d44e63d59fbf
Autor:
Rei Matsuki, Kenichi Okuda, Akihisa Mitani, Yasuhiro Yamauchi, Goh Tanaka, Haruki Kume, Yukio Homma, Munetoshi Hinata, Akimasa Hayashi, Junji Shibahara, Masashi Fukayama, Takahide Nagase
Publikováno v:
Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 158-163 (2017)
Temsirolimus is an inhibitor of mammalian target of rapamycin and interstitial lung disease (ILD) is known to be one of the adverse events associated with temsirolimus, which usually improves rapidly after discontinuation of the drug and rarely worse
Externí odkaz:
https://doaj.org/article/e9efecbc90924bf1868aba3b9250b5bc
Autor:
Naoya Miyashita, Takayoshi Enokido, Masafumi Horie, Hiroshi I. Suzuki, Rei Matsuki, Hans Brunnström, Patrick Micke, Takahide Nagase, Akira Saito
Publikováno v:
Cancer Research. 83:LB259-LB259
Background: Achaete-scute family bHLH transcription factor 1 (ASCL1) is a master transcription factor involved in neuroendocrine differentiation. ASCL1 is expressed in approximately 10% of lung adenocarcinomas and exerts tumor-promoting effects. Howe
Autor:
Goh Tanaka, Akihisa Mitani, Munetoshi Hinata, Junji Shibahara, Kenichi Okuda, Yukio Homma, Yasuhiro Yamauchi, Takahide Nagase, Haruki Kume, Akimasa Hayashi, Masashi Fukayama, Rei Matsuki
Publikováno v:
Respiratory Medicine Case Reports
Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 158-163 (2017)
Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 158-163 (2017)
Temsirolimus is an inhibitor of mammalian target of rapamycin and interstitial lung disease (ILD) is known to be one of the adverse events associated with temsirolimus, which usually improves rapidly after discontinuation of the drug and rarely worse